Andrea Morandi

4.3k total citations · 1 hit paper
49 papers, 2.9k citations indexed

About

Andrea Morandi is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Andrea Morandi has authored 49 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Cancer Research, 22 papers in Molecular Biology and 14 papers in Oncology. Recurrent topics in Andrea Morandi's work include Cancer, Hypoxia, and Metabolism (19 papers), Metabolism, Diabetes, and Cancer (9 papers) and Estrogen and related hormone effects (6 papers). Andrea Morandi is often cited by papers focused on Cancer, Hypoxia, and Metabolism (19 papers), Metabolism, Diabetes, and Cancer (9 papers) and Estrogen and related hormone effects (6 papers). Andrea Morandi collaborates with scholars based in Italy, United Kingdom and Switzerland. Andrea Morandi's co-authors include Paola Chiarugi, Elisa Giannoni, Luigi Ippolito, Maria Letizia Taddei, Stefano Indraccolo, Giuseppina Comito, Iván Plaza-Menacho, Clare M. Isacke, Marina Bacci and Nicla Lorito and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and PLoS ONE.

In The Last Decade

Andrea Morandi

47 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Lactate: A Metabolic Driver in the Tumour Landscape

2018 401 citations Luigi Ippolito, Andrea Morandi et al. Trends in Biochemical Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andrea Morandi Italy	29	1.7k	1.4k	787	429	389	49	2.9k
David Kung‐Chun Chiu Hong Kong	21	2.2k 1.3×	1.4k 1.0×	743 0.9×	367 0.9×	655 1.7×	36	3.3k
Elena Piskounova United States	13	2.9k 1.7×	1.7k 1.2×	895 1.1×	261 0.6×	328 0.8×	22	4.1k
Takaaki Takeda Japan	13	1.4k 0.8×	925 0.7×	838 1.1×	334 0.8×	227 0.6×	19	2.6k
Manabu Futamura Japan	28	1.4k 0.8×	729 0.5×	1.1k 1.3×	372 0.9×	312 0.8×	126	2.7k
Marta Pàez‐Ribes United Kingdom	15	1.9k 1.1×	1.1k 0.8×	1000 1.3×	452 1.1×	465 1.2×	18	3.2k
Tao Yin China	31	1.6k 1.0×	756 0.5×	1.1k 1.4×	201 0.5×	377 1.0×	89	2.7k
Gang Yang China	30	1.8k 1.1×	1.4k 1.0×	1.5k 1.9×	469 1.1×	535 1.4×	79	3.4k
Yixuan Hou China	26	1.8k 1.1×	1.4k 1.0×	765 1.0×	218 0.5×	290 0.7×	38	2.5k
Houjie Liang China	29	1.2k 0.7×	881 0.6×	711 0.9×	183 0.4×	340 0.9×	73	2.4k
Mei Yee Koh United States	19	1.3k 0.8×	1.5k 1.1×	379 0.5×	259 0.6×	223 0.6×	26	2.3k

Countries citing papers authored by Andrea Morandi

Since Specialization

Citations

This map shows the geographic impact of Andrea Morandi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrea Morandi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrea Morandi more than expected).

Fields of papers citing papers by Andrea Morandi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrea Morandi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrea Morandi. The network helps show where Andrea Morandi may publish in the future.

Co-authorship network of co-authors of Andrea Morandi

This figure shows the co-authorship network connecting the top 25 collaborators of Andrea Morandi. A scholar is included among the top collaborators of Andrea Morandi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrea Morandi. Andrea Morandi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ippolito, Luigi, Giuseppina Comito, Elisa Pardella, et al.. (2024). Lactate supports cell-autonomous ECM production to sustain metastatic behavior in prostate cancer. EMBO Reports. 25(8). 3506–3531. 21 indexed citations

Lorito, Nicla, et al.. (2023). Sex difference in liver diseases: How preclinical models help to dissect the sex-related mechanisms sustaining NAFLD and hepatocellular carcinoma. iScience. 26(12). 108363–108363. 20 indexed citations

Visani, Luca, Lorenzo Livi, Ivica Ratoša, et al.. (2022). Safety of CDK4/6 inhibitors and concomitant radiation therapy in patients affected by metastatic breast cancer. Radiotherapy and Oncology. 177. 40–45. 3 indexed citations

Grillo, Elisabetta, Michela Corsini, Cosetta Ravelli, et al.. (2021). Expression of activated VEGFR2 by R1051Q mutation alters the energy metabolism of Sk-Mel-31 melanoma cells by increasing glutamine dependence. Cancer Letters. 507. 80–88. 11 indexed citations

Bruschini, Luca, et al.. (2020). Bone Anchored Hearing Aids for the Treatment of Asymmetric Hearing Loss. The Journal of International Advanced Otology. 16(3). 313–317. 5 indexed citations

Kowalik, Marta Anna, Lavinia Cabras, Pia Sulas, et al.. (2020). Thyroid hormone inhibits hepatocellular carcinoma progression via induction of differentiation and metabolic reprogramming. Journal of Hepatology. 72(6). 1159–1169. 49 indexed citations

Taddei, Maria Letizia, Lorenzo Cavallini, Matteo Ramazzotti, et al.. (2018). Stromal‐induced downregulation of miR‐1247 promotes prostate cancer malignancy. Journal of Cellular Physiology. 234(6). 8274–8285. 22 indexed citations

Ippolito, Luigi, Andrea Morandi, Elisa Giannoni, & Paola Chiarugi. (2018). Lactate: A Metabolic Driver in the Tumour Landscape. Trends in Biochemical Sciences. 44(2). 153–166. 401 indexed citations breakdown →

Morandi, Andrea & Stefano Indraccolo. (2017). Linking metabolic reprogramming to therapy resistance in cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1868(1). 1–6. 132 indexed citations

10.

Bacci, Marina, Elisa Giannoni, Antony Fearns, et al.. (2016). miR-155 Drives Metabolic Reprogramming of ER+ Breast Cancer Cells Following Long-Term Estrogen Deprivation and Predicts Clinical Response to Aromatase Inhibitors. Cancer Research. 76(6). 1615–1626. 81 indexed citations

11.

Pietrobono, Silvia, Andrea Morandi, Sinforosa Gagliardi, et al.. (2016). Down-Regulation of SOX2 Underlies the Inhibitory Effects of the Triphenylmethane Gentian Violet on Melanoma Cell Self-Renewal and Survival. Journal of Investigative Dermatology. 136(10). 2059–2069. 34 indexed citations

12.

Ippolito, Luigi, Alberto Marini, Lorenzo Cavallini, et al.. (2016). Metabolic shift toward oxidative phosphorylation in docetaxel resistant prostate cancer cells. Oncotarget. 7(38). 61890–61904. 109 indexed citations

13.

Morandi, Andrea, Elisa Giannoni, & Paola Chiarugi. (2016). Nutrient Exploitation within the Tumor–Stroma Metabolic Crosstalk. Trends in cancer. 2(12). 736–746. 40 indexed citations

14.

Mattu, Sandra, Francesca Fornari, Luca Quagliata, et al.. (2015). The metabolic gene HAO2 is downregulated in hepatocellular carcinoma and predicts metastasis and poor survival. Journal of Hepatology. 64(4). 891–898. 32 indexed citations

15.

Taddei, Maria Letizia, Lorenzo Cavallini, Giuseppina Comito, et al.. (2014). Senescent stroma promotes prostate cancer progression: The role of miR‐210. Molecular Oncology. 8(8). 1729–1746. 105 indexed citations

16.

Morandi, Andrea, Lesley‐Ann Martin, Qiong Gao, et al.. (2013). GDNF–RET Signaling in ER-Positive Breast Cancers Is a Key Determinant of Response and Resistance to Aromatase Inhibitors. Cancer Research. 73(12). 3783–3795. 83 indexed citations

17.

Morandi, Andrea, Iván Plaza-Menacho, & Clare M. Isacke. (2011). RET in breast cancer: functional and therapeutic implications. Trends in Molecular Medicine. 17(3). 149–157. 72 indexed citations

18.

Plaza-Menacho, Iván, Andrea Morandi, Luca Mologni, et al.. (2011). Focal Adhesion Kinase (FAK) Binds RET Kinase via Its FERM Domain, Priming a Direct and Reciprocal RET-FAK Transactivation Mechanism. Journal of Biological Chemistry. 286(19). 17292–17302. 48 indexed citations

19.

Rovida, Elisabetta, Elena Spinelli, Sara Sdelci, et al.. (2008). ERK5/BMK1 Is Indispensable for Optimal Colony-Stimulating Factor 1 (CSF-1)-Induced Proliferation in Macrophages in a Src-Dependent Fashion. The Journal of Immunology. 180(6). 4166–4172. 53 indexed citations

20.

Barbetti, V, Antonella Gozzini, Elisabetta Rovida, et al.. (2007). Selective anti-leukaemic activity of low-dose histone deacetylase inhibitor ITF2357 on AML1/ETO-positive cells. Oncogene. 27(12). 1767–1778. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact